🟢 Vera Therapeutics is trading 11% up today in after-hours trading amid broader risk-on market sentiment

Vera Therapeutics is trading at $32.01 (+10.80%) after broader risk-on sentiment likely contributed to the gain.

• The S&P 500 rose 0.72% and Nasdaq advanced 1.01%; no new company-specific catalyst was identified on August 13, 2026. Vera Therapeutics’ latest official release was its August 10 earnings update.
• CEO Marshall Fordyce’s reported $1.96 million stock sale was disclosed August 13 but does not explain the after-hours gain.
• The company remains supported by TRUTAKNA’s accelerated FDA approval and an upcoming Q3 efficacy analysis.